ZoomMed: Renewal of a Major Contract of $ 850,000
(firmenpresse) - MONTREAL, QUEBEC -- (Marketwire) -- 05/29/12 -- ZoomMed inc. (TSX VENTURE: ZMD) developer of the ZRx Prescriber, is proud to announce the renewal of a one (1) year major contract for the use of its pharmacological information communication channel. Based on positives results, one of the Canadian pharmaceutical corporation leaders, having their headquarters in the USA, signed a corporate agreement totalling $ 850,000.
"Our communication network is undeniably recognized as a preferred solution, providing a great added value to the communication efforts of small and large pharmaceutical companies that seek to reach physicians. New drugs are continuously being introduced. On the other hand, physicians are overworked and have even less time to meet with pharmaceutical representatives. The wireless Internet connections and increased use of smartphones allow the growth of solutions previously unimaginable. In addition, the U.S. market, which we had acceded in 2011, confirms the same tendency." said Mr. Yves Marmet, President and CEO of ZoomMed.
To date, 16 major pharmaceutical corporations are actually using ZoomMed's health care communication network.
About ZoomMed
ZoomMed developed the ZRx Prescriber, a technological innovative Web application that enables physicians to use a wireless device, such as the IPod Touch™, IPhone™, IPad™, Google Android™, other PDA's or computers, to write and rapidly deliver scripts. The ZRx Prescriber is quick, efficient and intuitive. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).
ZoomMed's health care communication network is a clinical information exchange platform between physicians and the various other stakeholders of the health sector; pharmacists, specialists, pharmaceutical corporations, laboratories, specialized clinics and others.
Furthermore, ZoomMed also offers "PraxisLab" a new pharmacy management software that enhances all aspects of the prescription filling process and the complete pharmacists patient file management. PraxisLab uses state-of-the-art protocols and up-to-date software standards.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
ZoomMed
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, ext 228
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.05.2012 - 10:37 Uhr
Sprache: Deutsch
News-ID 1118765
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MONTREAL, QUEBEC
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 291 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ZoomMed: Renewal of a Major Contract of $ 850,000
"
steht unter der journalistisch-redaktionellen Verantwortung von
ZoomMed Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
